Secondary analysis of 445 patients with secondary progressive MS from the MS-SMART trial: hypertension and higher comorbidity count were associated with higher EDSS; hyperlipidaemia and comorbidity count with EDSS worsening over 96 weeks.
Secondary analysisn = 445
John et al. Vascular Comorbidities and an Increased Comorbidity Score Are Associated With Disability and Disability Progression in Secondary Progressive Multiple Sclerosis